Back to Search
Start Over
CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate
- Source :
- Leukemia. 22(2)
- Publication Year :
- 2007
-
Abstract
- CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate
- Subjects :
- Adult
Male
Cancer Research
CD34
Cell Count
IMATINIB
Piperazines
Bone Marrow
hemic and lymphatic diseases
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
medicine
Humans
Aged
CHRONIC MYELOID LEUKEMIA
business.industry
Remission Induction
Myeloid leukemia
Imatinib
Hematology
Middle Aged
Imatinib mesylate
Pyrimidines
Oncology
Immunology
Benzamides
Cancer research
Imatinib Mesylate
Female
business
medicine.drug
Subjects
Details
- ISSN :
- 14765551
- Volume :
- 22
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Leukemia
- Accession number :
- edsair.doi.dedup.....386bc642da9416284ae84f8bf3cdff03